Portefeuille d'ETF FBT (NYSE) - Page 2 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

HALO Halozyme Therapeutics Inc 41.22 M 612.51 K 3.10%

GILD Gilead Sciences Inc 41.12 M 335.05 K 3.10%

NBIX Neurocrine Biosciences Inc 40.76 M 287.36 K 3.07%

SRPT Sarepta Therapeutics Inc 38.23 M 1.78 M 2.88%

GMAB Genmab A/S 38.02 M 1.23 M 2.86%

ONC BeOne Medicines Ltd 37.26 M 122.66 K 2.81%

BNTX BioNTech SE 36.62 M 384.69 K 2.76%

ALKS Alkermes PLC 35.20 M 1.26 M 2.65%

ALNY Alnylam Pharmaceuticals Inc 33.93 M 85.32 K 2.55%

CORT Corcept Therapeutics Inc 18.47 M 530.85 K 1.39%

BOFA SECURITIES, INC. 6.46 M 6.46 M 0.49%

Dreyfus Government Cash Management 959.08 K 959.08 K 0.07%

1
2

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil